Fragment-Based Drug Discovery Market – High Spending
Fragment-Based Drug Discovery Market: Overview
The introduction of new techniques into existing fragment-based drug discovery practices has created significant reductions in time and cost, which has driven the demand for such practices. Combinatorial chemistry and high-throughput screening are some of the most recently introduced practices that have helped make fragment-based drug discovery programs much faster and cheaper than before.
Presentation of the report: https://www.transparencymarketresearch.com/fragment-based-drug-discovery-market.html
Additionally, as the use of fragment-based drug discovery grows in the area of weaker inhibitor discovery, biophysical techniques become extremely useful. These techniques can be used to measure binding within moiety compounds that possess low affinity for binding.
The demand for fragment-based drug discovery, however, is expected to be severely hampered by the reduced power of fragment screening, the most popular component, in some compounds. The drugs generated are of lower potency than required, thus deterring many end users from approaching this technique.
Sample request: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4741
The collective impact of all these drivers and restraints can be seen in the global fragment-based drug discovery market, which is expected to grow at a CAGR of 14.4% from 2015 to 2023 in terms of revenue. By the end of 2016, these revenues are expected to reach $435.6 million and $1.15 billion by the end of 2023.
North America is expected to continue to be the top demand for fragment-based drug discovery programs
By the end of 2023, the market value of fragment-based drug discovery techniques in North America is expected to account for 45.4% of the global market. Although this is a decline in market value from its 2014 stats, North America will still enjoy being a leading geographic segment for advancements in drug-based drug discovery techniques. of fragments.
The major factors responsible for North America’s leading role in fragment-based drug discovery programs are the high rate of research and development efforts undertaken by major market players in the region. Both the United States and Canada are countries with advanced healthcare systems and infrastructure, and are often the basis for advanced technological implementations, making North America the hub of the latest developments in fragment-based drug discovery.
Inquiry before buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=4741
This region is also accelerating its speed of developing fragment-based drug discovery techniques by employing Asia-Pacific outsourcing facilities. The demand for fragment-based drug discovery in Asia-Pacific, on the other hand, is much higher than in any other major region, due to rapid improvements in healthcare infrastructure and a focus on better management of the disease. quality in countries like Japan and China.
Biopharmaceutical companies top the list in demand for fragment-based drug discovery
Fragment-based drug discovery techniques have grown significantly in popularity in recent years and have found a wide range of uses in biopharmaceuticals. This includes large corporations, academic bodies, and CROs. These techniques have helped enormously in creating chemical series that possess lead-like properties, as they have significantly improved the success rate of creation compared to conventional screening methods. Fragment-based drug discovery techniques have also been extremely useful in labeling chemical motifs from multiple targets.
Request a brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4741
It is a combination of all these factors that is expected to drive the use of fragment-based drug discovery in biopharmaceutical facilities to generate revenue of US$565.2 million by the end of 2023. Leading providers of fragment-based drug discovery programs include Astex Pharmaceuticals, Charles River Laboratories International, Inc., Sygnature Discovery, Evotec AG and Beactica AB.
Request for covid19 impact analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4741
Transparency Market Research Inc.
HEADQUARTERS IN THE CITY CENTER,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
United States – Canada Toll Free: 866-552-3453
Email: [email protected]
About Transparency Market Research
Transparency Market Research registered in Wilmington, Delaware, USA, is a global market research firm providing custom research and consulting services. TMR provides detailed information on the factors driving the demand in the market. It discloses opportunities in various segments based on source, application, sales channel, and end use that will drive market growth over the next 9 years.
Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With broad research and analytical capability, Transparency Market Research uses rigorous primary and secondary research techniques to develop distinctive datasets and research material for trade reports.
For more information on research on leading industries, visit our YouTube channel and click subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
This press release was published on openPR.